pharmaobservatory 0.1.8 → 0.1.9
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +84 -9
- data/docs/AnimalWelfareAssurancesResponse.md +58 -0
- data/docs/{BiomarkerAssayEvidenceResponseBuild.md → AnimalWelfareAssurancesResponseBuild.md} +2 -2
- data/docs/{BiomarkerAssayEvidenceResponseFreshness.md → AnimalWelfareAssurancesResponseFreshness.md} +2 -2
- data/docs/{BiomarkerAssayEvidenceResponseScope.md → AnimalWelfareAssurancesResponseScope.md} +2 -2
- data/docs/AnimalWelfareAssurancesRow.md +48 -0
- data/docs/BiomarkerAlleleFrequenciesResponse.md +3 -3
- data/docs/BiomarkerAssayEvidenceResponse.md +3 -3
- data/docs/BiomarkerAssayProvidersResponse.md +3 -3
- data/docs/BiomarkerAssayWhitespaceResponse.md +3 -3
- data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
- data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
- data/docs/BiomarkerEvidenceByYearResponse.md +3 -3
- data/docs/BiomarkerEvidenceResponse.md +3 -3
- data/docs/BiomarkerLiteratureResponse.md +3 -3
- data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
- data/docs/BiomarkerRelationsResponse.md +3 -3
- data/docs/BiomarkerSampleCoverageResponse.md +3 -3
- data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
- data/docs/BiomarkerTraversalStatusResponse.md +3 -3
- data/docs/BiomarkerValidationResponse.md +3 -3
- data/docs/BiomarkerVariantMentionsResponse.md +3 -3
- data/docs/BiomarkersRecord.md +2 -2
- data/docs/BiomarkersResponse.md +3 -3
- data/docs/BrandCompaniesResponse.md +3 -3
- data/docs/BrandRevenueResponse.md +3 -3
- data/docs/CatalystsResponse.md +3 -3
- data/docs/CellLinesRecord.md +2 -2
- data/docs/CellLinesResponse.md +3 -3
- data/docs/CliaCertificatesResponse.md +3 -3
- data/docs/CompaniesApi.md +928 -108
- data/docs/CompaniesRecord.md +2 -2
- data/docs/CompaniesRecordAttributes.md +2 -0
- data/docs/CompaniesResponse.md +3 -3
- data/docs/CompanyAssetsResponse.md +3 -3
- data/docs/CompanyAssetsRow.md +1 -5
- data/docs/CompanyBiomarkerCapabilityResponse.md +3 -3
- data/docs/CompanyCollaboratorsResponse.md +58 -0
- data/docs/CompanyCollaboratorsRow.md +42 -0
- data/docs/CompanyCompetitorActivityResponse.md +58 -0
- data/docs/CompanyCompetitorActivityRow.md +42 -0
- data/docs/CompanyCompetitorsResponse.md +58 -0
- data/docs/CompanyCompetitorsRow.md +66 -0
- data/docs/CompanyFinancialsResponse.md +58 -0
- data/docs/CompanyFinancialsRow.md +108 -0
- data/docs/CompanyFirmographicsResponse.md +58 -0
- data/docs/CompanyFirmographicsRow.md +80 -0
- data/docs/CompanyFundingEventsResponse.md +3 -3
- data/docs/CompanyFundingSummaryResponse.md +3 -3
- data/docs/CompanyMembersResponse.md +3 -3
- data/docs/CompanyProgramsResponse.md +3 -3
- data/docs/CompanyProgramsRow.md +1 -5
- data/docs/CompanyRareDiseaseDeclarationsResponse.md +3 -3
- data/docs/CompanyTargetsResponse.md +3 -3
- data/docs/CompanyTimelineResponse.md +58 -0
- data/docs/CompanyTimelineRow.md +68 -0
- data/docs/CompanyTrialGeographyResponse.md +3 -3
- data/docs/CompanyTrialSitesResponse.md +3 -3
- data/docs/CompanyUsPatentsResponse.md +58 -0
- data/docs/CompanyUsPatentsRow.md +34 -0
- data/docs/ConditionAdverseEventsResponse.md +3 -3
- data/docs/ConditionBurdenResponse.md +3 -3
- data/docs/ConditionDeliveryResponse.md +3 -3
- data/docs/ConditionDrugsResponse.md +3 -3
- data/docs/ConditionInvestigatorOrganizationsResponse.md +58 -0
- data/docs/ConditionInvestigatorOrganizationsRow.md +44 -0
- data/docs/ConditionPrevalenceResponse.md +3 -3
- data/docs/ConditionPublicationsResponse.md +3 -3
- data/docs/ConditionRecruitmentByPhaseResponse.md +3 -3
- data/docs/ConditionRecruitmentDurationResponse.md +3 -3
- data/docs/ConditionSitesResponse.md +3 -3
- data/docs/ConditionTrialStartForecastResponse.md +3 -3
- data/docs/ConditionTrialsResponse.md +3 -3
- data/docs/ConditionsApi.md +160 -0
- data/docs/ConditionsRecord.md +2 -2
- data/docs/ConditionsResponse.md +3 -3
- data/docs/CroFootprintResponse.md +3 -3
- data/docs/CroTrialsResponse.md +3 -3
- data/docs/DebarmentsResponse.md +3 -3
- data/docs/DrugApprovalsResponse.md +3 -3
- data/docs/DrugAspCodesResponse.md +3 -3
- data/docs/DrugBrandsResponse.md +3 -3
- data/docs/DrugCombinationsResponse.md +3 -3
- data/docs/DrugDeclaredPatentsResponse.md +3 -3
- data/docs/DrugInvestigatorsResponse.md +58 -0
- data/docs/DrugInvestigatorsRow.md +32 -0
- data/docs/DrugLabelSafetyResponse.md +3 -3
- data/docs/DrugMedicareSpendResponse.md +3 -3
- data/docs/DrugPatentCliffResponse.md +3 -3
- data/docs/DrugPatentMentionsResponse.md +3 -3
- data/docs/DrugPatentOwnersResponse.md +3 -3
- data/docs/DrugPricingResponse.md +3 -3
- data/docs/DrugRecallsResponse.md +3 -3
- data/docs/DrugRegulatoryResponse.md +3 -3
- data/docs/DrugSitesResponse.md +3 -3
- data/docs/DrugTargetsResponse.md +3 -3
- data/docs/DrugTrialConditionsResponse.md +3 -3
- data/docs/DrugTrialsResponse.md +3 -3
- data/docs/DrugVariantsResponse.md +3 -3
- data/docs/DrugsApi.md +80 -0
- data/docs/DrugsRecord.md +2 -2
- data/docs/DrugsResponse.md +3 -3
- data/docs/EnforcementEventsResponse.md +3 -3
- data/docs/EnforcementEventsRow.md +22 -4
- data/docs/GxpFacilitiesResponse.md +3 -3
- data/docs/GxpFacilitiesRow.md +27 -1
- data/docs/HospitalBedsYearlyResponse.md +3 -3
- data/docs/HospitalFacilityChangesResponse.md +3 -3
- data/docs/HospitalsApi.md +80 -0
- data/docs/HospitalsRecord.md +2 -2
- data/docs/HospitalsResponse.md +3 -3
- data/docs/ImportRefusalsResponse.md +3 -3
- data/docs/InspectionFindingsResponse.md +3 -3
- data/docs/InspectionsResponse.md +3 -3
- data/docs/InstitutionalHoldingsResponse.md +3 -3
- data/docs/InstitutionalQuarterTotalsResponse.md +3 -3
- data/docs/InvestigatorConditionsResponse.md +58 -0
- data/docs/InvestigatorConditionsRow.md +28 -0
- data/docs/InvestigatorDebarmentsResponse.md +58 -0
- data/docs/InvestigatorDebarmentsRow.md +32 -0
- data/docs/InvestigatorHospitalsResponse.md +58 -0
- data/docs/InvestigatorHospitalsRow.md +28 -0
- data/docs/InvestigatorInspectionsResponse.md +58 -0
- data/docs/InvestigatorInspectionsRow.md +46 -0
- data/docs/InvestigatorPublicationsResponse.md +58 -0
- data/docs/InvestigatorPublicationsRow.md +34 -0
- data/docs/InvestigatorTopicsResponse.md +58 -0
- data/docs/InvestigatorTopicsRow.md +34 -0
- data/docs/InvestigatorTrialsResponse.md +58 -0
- data/docs/InvestigatorTrialsRow.md +64 -0
- data/docs/InvestigatorsApi.md +1113 -0
- data/docs/InvestigatorsRecord.md +38 -0
- data/docs/InvestigatorsResponse.md +58 -0
- data/docs/InvestigatorsRow.md +70 -0
- data/docs/InvestorFundsResponse.md +3 -3
- data/docs/InvestorPortfolioResponse.md +3 -3
- data/docs/InvestorPrivateFundsResponse.md +3 -3
- data/docs/InvestorsRecord.md +2 -2
- data/docs/InvestorsResponse.md +3 -3
- data/docs/InvestorsRow.md +6 -0
- data/docs/LegalEntitiesApi.md +244 -4
- data/docs/LegalEntitiesRecord.md +2 -2
- data/docs/LegalEntitiesResponse.md +3 -3
- data/docs/LegalEntitySecFilingsResponse.md +3 -3
- data/docs/ManagersRecord.md +2 -2
- data/docs/ManagersResponse.md +3 -3
- data/docs/OrgDisclosureTrendResponse.md +3 -3
- data/docs/OrgDisclosuresResponse.md +3 -3
- data/docs/OrgRelationshipsResponse.md +3 -3
- data/docs/OwnershipObservationsResponse.md +58 -0
- data/docs/OwnershipObservationsRow.md +168 -0
- data/docs/OwnershipPercentagesResponse.md +3 -3
- data/docs/OwnershipPositionsResponse.md +3 -3
- data/docs/OwnershipSourceCoverageResponse.md +3 -3
- data/docs/PdufaDatesResponse.md +3 -3
- data/docs/ProgramLicensingCandidatesResponse.md +3 -3
- data/docs/ProgramLicensingCandidatesRow.md +1 -5
- data/docs/ProgramsResponse.md +3 -3
- data/docs/ProgramsRow.md +1 -1
- data/docs/RareDiseaseGenesResponse.md +3 -3
- data/docs/RareDiseaseHierarchyResponse.md +3 -3
- data/docs/RareDiseaseInvestigatorCoverageResponse.md +3 -3
- data/docs/RareDiseaseInvestigatorsResponse.md +3 -3
- data/docs/RareDiseaseMappingsResponse.md +3 -3
- data/docs/RareDiseaseOrganizationsResponse.md +3 -3
- data/docs/RareDiseasePrevalenceResponse.md +3 -3
- data/docs/RareDiseaseRarityEvidenceResponse.md +3 -3
- data/docs/RareDiseaseRarityResponse.md +3 -3
- data/docs/RareDiseaseReplacementsResponse.md +3 -3
- data/docs/RareDiseaseSiteCoverageResponse.md +3 -3
- data/docs/RareDiseaseSponsorsResponse.md +3 -3
- data/docs/RareDiseaseTrialCoverageResponse.md +3 -3
- data/docs/RareDiseaseTrialSitesResponse.md +3 -3
- data/docs/RareDiseaseTrialsResponse.md +3 -3
- data/docs/RareDiseasesRecord.md +2 -2
- data/docs/RareDiseasesResponse.md +3 -3
- data/docs/RecallsResponse.md +3 -3
- data/docs/RwdConductorDeliveryResponse.md +3 -3
- data/docs/RwdConductorFootprintResponse.md +3 -3
- data/docs/RwdConductorStudiesResponse.md +3 -3
- data/docs/RwdConductorsRecord.md +2 -2
- data/docs/RwdConductorsResponse.md +3 -3
- data/docs/RwdCoverageResponse.md +3 -3
- data/docs/RwdInstitutionsRecord.md +2 -2
- data/docs/RwdInstitutionsResponse.md +3 -3
- data/docs/RwdNetworksRecord.md +2 -2
- data/docs/RwdNetworksResponse.md +3 -3
- data/docs/RwdRegisterProvenanceResponse.md +3 -3
- data/docs/RwdRegistersRecord.md +2 -2
- data/docs/RwdSourceAgeBandsResponse.md +3 -3
- data/docs/RwdSourceConditionsResponse.md +3 -3
- data/docs/RwdSourceEtlMappingsResponse.md +3 -3
- data/docs/RwdSourceLinkagesResponse.md +3 -3
- data/docs/RwdSourceTypesResponse.md +3 -3
- data/docs/RwdSourceVocabulariesResponse.md +3 -3
- data/docs/RwdSourcesRecord.md +2 -2
- data/docs/RwdSourcesResponse.md +3 -3
- data/docs/RwdStudiesRecord.md +2 -2
- data/docs/RwdStudiesResponse.md +3 -3
- data/docs/RwdStudyConditionsResponse.md +3 -3
- data/docs/RwdStudyDataSourcesResponse.md +3 -3
- data/docs/RwdStudyDrugsResponse.md +3 -3
- data/docs/RwdStudyMilestonesResponse.md +3 -3
- data/docs/RwdWithheldFieldsResponse.md +3 -3
- data/docs/SbtiCrosscheckResponse.md +3 -3
- data/docs/SecPdufaDatesResponse.md +3 -3
- data/docs/SiteBedsYearlyResponse.md +3 -3
- data/docs/SiteCroTrialsResponse.md +3 -3
- data/docs/SiteHospitalsResponse.md +3 -3
- data/docs/SiteInvestigatorsResponse.md +3 -3
- data/docs/SiteTrialConditionsResponse.md +3 -3
- data/docs/SiteTrialDrugsResponse.md +3 -3
- data/docs/SiteTrialsResponse.md +3 -3
- data/docs/SitesRecord.md +2 -2
- data/docs/SitesResponse.md +3 -3
- data/docs/SponsorDeliveryResponse.md +3 -3
- data/docs/SponsorPatentMentionsResponse.md +3 -3
- data/docs/SponsorPublicationsResponse.md +58 -0
- data/docs/SponsorPublicationsRow.md +42 -0
- data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
- data/docs/SponsorRecruitmentDurationResponse.md +3 -3
- data/docs/SponsorTrialConditionsResponse.md +3 -3
- data/docs/SponsorTrialDrugsResponse.md +3 -3
- data/docs/SponsorTrialStartForecastResponse.md +3 -3
- data/docs/SponsorTrialsResponse.md +3 -3
- data/docs/SupplierCapabilityEsgResponse.md +3 -3
- data/docs/SupplierServicesResponse.md +3 -3
- data/docs/SupplierSitesResponse.md +3 -3
- data/docs/SuppliersRecord.md +2 -2
- data/docs/SuppliersResponse.md +3 -3
- data/docs/SuppliersRow.md +2 -0
- data/docs/TargetAssociationsResponse.md +3 -3
- data/docs/TargetCrowdingResponse.md +3 -3
- data/docs/TargetDrugsResponse.md +3 -3
- data/docs/TargetEvidenceResponse.md +3 -3
- data/docs/TargetInvestigatorsResponse.md +58 -0
- data/docs/TargetInvestigatorsRow.md +30 -0
- data/docs/TargetPatentMentionsResponse.md +3 -3
- data/docs/TargetProgramsResponse.md +3 -3
- data/docs/TargetPublicationsResponse.md +3 -3
- data/docs/TargetRegulatoryPrecedentResponse.md +3 -3
- data/docs/TargetTrialsResponse.md +3 -3
- data/docs/TargetsApi.md +80 -0
- data/docs/TargetsRecord.md +2 -2
- data/docs/TargetsResponse.md +3 -3
- data/docs/TrialAdverseEventsResponse.md +3 -3
- data/docs/TrialChangesResponse.md +3 -3
- data/docs/TrialDeliveryResponse.md +3 -3
- data/docs/TrialDemographicsResponse.md +3 -3
- data/docs/TrialDrugClassesResponse.md +3 -3
- data/docs/TrialDrugsResponse.md +3 -3
- data/docs/TrialEnrollmentHistoryResponse.md +3 -3
- data/docs/TrialEnrollmentRateResponse.md +3 -3
- data/docs/TrialExtractedEndpointsResponse.md +3 -3
- data/docs/TrialKolsResponse.md +3 -3
- data/docs/TrialOutcomeMeasuresResponse.md +3 -3
- data/docs/TrialResearchPaymentsResponse.md +3 -3
- data/docs/TrialSiteHistoryResponse.md +3 -3
- data/docs/TrialSitesResponse.md +3 -3
- data/docs/TrialsRecord.md +2 -2
- data/docs/TrialsResponse.md +3 -3
- data/docs/UnmatchedProductRevenueResponse.md +3 -3
- data/docs/UntitledLettersResponse.md +3 -3
- data/docs/WarningLettersResponse.md +3 -3
- data/lib/pharmaobservatory/api/companies_api.rb +1032 -122
- data/lib/pharmaobservatory/api/conditions_api.rb +168 -0
- data/lib/pharmaobservatory/api/drugs_api.rb +84 -0
- data/lib/pharmaobservatory/api/hospitals_api.rb +84 -0
- data/lib/pharmaobservatory/api/investigators_api.rb +1169 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +254 -2
- data/lib/pharmaobservatory/api/targets_api.rb +84 -0
- data/lib/pharmaobservatory/models/animal_welfare_assurances_response.rb +478 -0
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_build.rb → animal_welfare_assurances_response_build.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_freshness.rb → animal_welfare_assurances_response_freshness.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_scope.rb → animal_welfare_assurances_response_scope.rb} +3 -3
- data/lib/pharmaobservatory/models/animal_welfare_assurances_row.rb +392 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
- data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
- data/lib/pharmaobservatory/models/brand_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/brand_revenue_response.rb +3 -3
- data/lib/pharmaobservatory/models/catalysts_response.rb +3 -3
- data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
- data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
- data/lib/pharmaobservatory/models/clia_certificates_response.rb +3 -3
- data/lib/pharmaobservatory/models/companies_record.rb +2 -2
- data/lib/pharmaobservatory/models/companies_record_attributes.rb +10 -1
- data/lib/pharmaobservatory/models/companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_assets_row.rb +2 -24
- data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_collaborators_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_collaborators_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_competitor_activity_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_competitor_activity_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_competitors_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_competitors_row.rb +493 -0
- data/lib/pharmaobservatory/models/company_financials_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_financials_row.rb +718 -0
- data/lib/pharmaobservatory/models/company_firmographics_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_firmographics_row.rb +566 -0
- data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_programs_row.rb +2 -24
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_timeline_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_timeline_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_trial_geography_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_us_patents_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_us_patents_row.rb +311 -0
- data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_investigator_organizations_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_investigator_organizations_row.rb +366 -0
- data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
- data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/cro_footprint_response.rb +3 -3
- data/lib/pharmaobservatory/models/cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/debarments_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_approvals_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_asp_codes_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_brands_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_combinations_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_declared_patents_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_investigators_row.rb +302 -0
- data/lib/pharmaobservatory/models/drug_label_safety_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_medicare_spend_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_owners_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_pricing_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_recalls_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_regulatory_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_variants_response.rb +3 -3
- data/lib/pharmaobservatory/models/drugs_record.rb +2 -2
- data/lib/pharmaobservatory/models/drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/enforcement_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/enforcement_events_row.rb +104 -5
- data/lib/pharmaobservatory/models/gxp_facilities_response.rb +3 -3
- data/lib/pharmaobservatory/models/gxp_facilities_row.rb +145 -2
- data/lib/pharmaobservatory/models/hospital_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/hospital_facility_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/hospitals_record.rb +2 -2
- data/lib/pharmaobservatory/models/hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/import_refusals_response.rb +3 -3
- data/lib/pharmaobservatory/models/inspection_findings_response.rb +3 -3
- data/lib/pharmaobservatory/models/inspections_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_quarter_totals_response.rb +3 -3
- data/lib/pharmaobservatory/models/investigator_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_conditions_row.rb +278 -0
- data/lib/pharmaobservatory/models/investigator_debarments_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_debarments_row.rb +300 -0
- data/lib/pharmaobservatory/models/investigator_hospitals_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_hospitals_row.rb +280 -0
- data/lib/pharmaobservatory/models/investigator_inspections_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_inspections_row.rb +377 -0
- data/lib/pharmaobservatory/models/investigator_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_publications_row.rb +311 -0
- data/lib/pharmaobservatory/models/investigator_topics_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_topics_row.rb +311 -0
- data/lib/pharmaobservatory/models/investigator_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_trials_row.rb +478 -0
- data/lib/pharmaobservatory/models/investigators_record.rb +385 -0
- data/lib/pharmaobservatory/models/investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigators_row.rb +511 -0
- data/lib/pharmaobservatory/models/investor_funds_response.rb +3 -3
- data/lib/pharmaobservatory/models/investor_portfolio_response.rb +3 -3
- data/lib/pharmaobservatory/models/investor_private_funds_response.rb +3 -3
- data/lib/pharmaobservatory/models/investors_record.rb +2 -2
- data/lib/pharmaobservatory/models/investors_response.rb +3 -3
- data/lib/pharmaobservatory/models/investors_row.rb +34 -1
- data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
- data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +3 -3
- data/lib/pharmaobservatory/models/managers_record.rb +2 -2
- data/lib/pharmaobservatory/models/managers_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_disclosures_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_relationships_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_observations_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_observations_row.rb +1048 -0
- data/lib/pharmaobservatory/models/ownership_percentages_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/program_licensing_candidates_response.rb +3 -3
- data/lib/pharmaobservatory/models/program_licensing_candidates_row.rb +2 -24
- data/lib/pharmaobservatory/models/programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/programs_row.rb +1 -1
- data/lib/pharmaobservatory/models/rare_disease_genes_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_hierarchy_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_mappings_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_organizations_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_rarity_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_replacements_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_site_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_sponsors_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trial_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_diseases_record.rb +2 -2
- data/lib/pharmaobservatory/models/rare_diseases_response.rb +3 -3
- data/lib/pharmaobservatory/models/recalls_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductors_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_conductors_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_institutions_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_institutions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_networks_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_networks_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_register_provenance_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_registers_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_source_age_bands_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_etl_mappings_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_linkages_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_types_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_vocabularies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_sources_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_sources_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_studies_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_studies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_data_sources_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_milestones_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_withheld_fields_response.rb +3 -3
- data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +3 -3
- data/lib/pharmaobservatory/models/sec_pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/sites_record.rb +2 -2
- data/lib/pharmaobservatory/models/sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_publications_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_services_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/suppliers_record.rb +2 -2
- data/lib/pharmaobservatory/models/suppliers_response.rb +3 -3
- data/lib/pharmaobservatory/models/suppliers_row.rb +12 -1
- data/lib/pharmaobservatory/models/target_associations_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_crowding_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_investigators_row.rb +291 -0
- data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/targets_record.rb +2 -2
- data/lib/pharmaobservatory/models/targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_kols_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_research_payments_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_site_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/trials_record.rb +2 -2
- data/lib/pharmaobservatory/models/trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/unmatched_product_revenue_response.rb +3 -3
- data/lib/pharmaobservatory/models/untitled_letters_response.rb +3 -3
- data/lib/pharmaobservatory/models/warning_letters_response.rb +3 -3
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +47 -3
- metadata +96 -8
data/docs/CompaniesRecord.md
CHANGED
|
@@ -11,8 +11,8 @@
|
|
|
11
11
|
| **datasets** | [**Array<DatasetListing>**](DatasetListing.md) | | |
|
|
12
12
|
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
13
13
|
| **source_credit** | **String** | | [optional] |
|
|
14
|
-
| **freshness** | [**
|
|
15
|
-
| **build** | [**
|
|
14
|
+
| **freshness** | [**AnimalWelfareAssurancesResponseFreshness**](AnimalWelfareAssurancesResponseFreshness.md) | | [optional] |
|
|
15
|
+
| **build** | [**AnimalWelfareAssurancesResponseBuild**](AnimalWelfareAssurancesResponseBuild.md) | | [optional] |
|
|
16
16
|
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
17
17
|
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
18
18
|
|
|
@@ -4,6 +4,7 @@
|
|
|
4
4
|
|
|
5
5
|
| Name | Type | Description | Notes |
|
|
6
6
|
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **company_firmographics** | [**CompanyFirmographicsRow**](CompanyFirmographicsRow.md) | | [optional] |
|
|
7
8
|
| **company_funding_summary** | [**CompanyFundingSummaryRow**](CompanyFundingSummaryRow.md) | | [optional] |
|
|
8
9
|
| **company_trial_geography** | [**CompanyTrialGeographyRow**](CompanyTrialGeographyRow.md) | | [optional] |
|
|
9
10
|
|
|
@@ -13,6 +14,7 @@
|
|
|
13
14
|
require 'pharmaobservatory'
|
|
14
15
|
|
|
15
16
|
instance = PharmaObservatory::CompaniesRecordAttributes.new(
|
|
17
|
+
company_firmographics: null,
|
|
16
18
|
company_funding_summary: null,
|
|
17
19
|
company_trial_geography: null
|
|
18
20
|
)
|
data/docs/CompaniesResponse.md
CHANGED
|
@@ -8,7 +8,7 @@
|
|
|
8
8
|
| **grain** | **String** | | [optional] |
|
|
9
9
|
| **object_type** | **String** | | [optional] |
|
|
10
10
|
| **id** | **String** | | [optional] |
|
|
11
|
-
| **scope** | [**
|
|
11
|
+
| **scope** | [**AnimalWelfareAssurancesResponseScope**](AnimalWelfareAssurancesResponseScope.md) | | [optional] |
|
|
12
12
|
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
13
|
| **rows** | [**Array<CompaniesRow>**](CompaniesRow.md) | | |
|
|
14
14
|
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
@@ -21,8 +21,8 @@
|
|
|
21
21
|
| **source_credit** | **String** | | [optional] |
|
|
22
22
|
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
23
|
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
-
| **freshness** | [**
|
|
25
|
-
| **build** | [**
|
|
24
|
+
| **freshness** | [**AnimalWelfareAssurancesResponseFreshness**](AnimalWelfareAssurancesResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**AnimalWelfareAssurancesResponseBuild**](AnimalWelfareAssurancesResponseBuild.md) | | [optional] |
|
|
26
26
|
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
27
|
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
28
|
|
|
@@ -8,7 +8,7 @@
|
|
|
8
8
|
| **grain** | **String** | | [optional] |
|
|
9
9
|
| **object_type** | **String** | | [optional] |
|
|
10
10
|
| **id** | **String** | | [optional] |
|
|
11
|
-
| **scope** | [**
|
|
11
|
+
| **scope** | [**AnimalWelfareAssurancesResponseScope**](AnimalWelfareAssurancesResponseScope.md) | | [optional] |
|
|
12
12
|
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
13
|
| **rows** | [**Array<CompanyAssetsRow>**](CompanyAssetsRow.md) | | |
|
|
14
14
|
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
@@ -21,8 +21,8 @@
|
|
|
21
21
|
| **source_credit** | **String** | | [optional] |
|
|
22
22
|
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
23
|
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
-
| **freshness** | [**
|
|
25
|
-
| **build** | [**
|
|
24
|
+
| **freshness** | [**AnimalWelfareAssurancesResponseFreshness**](AnimalWelfareAssurancesResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**AnimalWelfareAssurancesResponseBuild**](AnimalWelfareAssurancesResponseBuild.md) | | [optional] |
|
|
26
26
|
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
27
|
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
28
|
|
data/docs/CompanyAssetsRow.md
CHANGED
|
@@ -12,9 +12,7 @@
|
|
|
12
12
|
| **sponsor_group_name** | **String** | Display name of the sponsor's group. | [optional] |
|
|
13
13
|
| **drug_id** | **String** | The drug key. | [optional] |
|
|
14
14
|
| **drug_name** | **String** | The drug's name. | [optional] |
|
|
15
|
-
| **max_phase** | **Integer** | Highest phase the sponsor reached on the drug
|
|
16
|
-
| **max_phase_label** | **String** | The furthest phase reached with the split phases kept: Early 1, Phase 1, Phase 1/2, Phase 2, Phase 2/3, Phase 3, Phase 4, or Not reported. max_phase is the same value folded onto 0 to 4 (a split phase counts as its higher phase). | [optional] |
|
|
17
|
-
| **max_phase_fine_rank** | **Integer** | The finest phase rank behind max_phase_label: 6 Phase 4, 5 Phase 3, 4 Phase 2/3, 3 Phase 2, 2 Phase 1/2, 1 Phase 1, 0 Early 1, -1 not reported. Sort on it to order programs by furthest phase with the split phases kept; max_phase is the same value folded onto 0 to 4. | [optional] |
|
|
15
|
+
| **max_phase** | **Integer** | Highest phase the sponsor reached on the drug: 0 early phase 1 through 6 for phase 4 (marketed); -1 when unstated. | [optional] |
|
|
18
16
|
| **n_trials** | **Integer** | Distinct trials this sponsor leads on the drug. Counted once per trial within the sponsor organization, so it is not additive across a company's organizations. | [optional] |
|
|
19
17
|
| **n_active** | **Integer** | Of those trials, the number recruiting, not yet recruiting, active or enrolling by invitation. | [optional] |
|
|
20
18
|
| **last_year** | **Integer** | Latest start year among those trials. | [optional] |
|
|
@@ -35,8 +33,6 @@ instance = PharmaObservatory::CompanyAssetsRow.new(
|
|
|
35
33
|
drug_id: null,
|
|
36
34
|
drug_name: null,
|
|
37
35
|
max_phase: null,
|
|
38
|
-
max_phase_label: null,
|
|
39
|
-
max_phase_fine_rank: null,
|
|
40
36
|
n_trials: null,
|
|
41
37
|
n_active: null,
|
|
42
38
|
last_year: null,
|
|
@@ -8,7 +8,7 @@
|
|
|
8
8
|
| **grain** | **String** | | [optional] |
|
|
9
9
|
| **object_type** | **String** | | [optional] |
|
|
10
10
|
| **id** | **String** | | [optional] |
|
|
11
|
-
| **scope** | [**
|
|
11
|
+
| **scope** | [**AnimalWelfareAssurancesResponseScope**](AnimalWelfareAssurancesResponseScope.md) | | [optional] |
|
|
12
12
|
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
13
|
| **rows** | [**Array<CompanyBiomarkerCapabilityRow>**](CompanyBiomarkerCapabilityRow.md) | | |
|
|
14
14
|
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
@@ -21,8 +21,8 @@
|
|
|
21
21
|
| **source_credit** | **String** | | [optional] |
|
|
22
22
|
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
23
|
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
-
| **freshness** | [**
|
|
25
|
-
| **build** | [**
|
|
24
|
+
| **freshness** | [**AnimalWelfareAssurancesResponseFreshness**](AnimalWelfareAssurancesResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**AnimalWelfareAssurancesResponseBuild**](AnimalWelfareAssurancesResponseBuild.md) | | [optional] |
|
|
26
26
|
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
27
|
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
28
|
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyCollaboratorsResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**AnimalWelfareAssurancesResponseScope**](AnimalWelfareAssurancesResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<CompanyCollaboratorsRow>**](CompanyCollaboratorsRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**AnimalWelfareAssurancesResponseFreshness**](AnimalWelfareAssurancesResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**AnimalWelfareAssurancesResponseBuild**](AnimalWelfareAssurancesResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::CompanyCollaboratorsResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,42 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyCollaboratorsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **company_id** | **String** | Company level: the company the row is about; the entry key for the companies object type. | [optional] |
|
|
8
|
+
| **company_name** | **String** | Display name of the company. | [optional] |
|
|
9
|
+
| **group_id** | **String** | Group level: the company's current ultimate parent; a root's group is itself. | [optional] |
|
|
10
|
+
| **group_name** | **String** | Display name of the group. | [optional] |
|
|
11
|
+
| **condition_id** | **String** | The condition key, a MeSH (Medical Subject Headings) descriptor id (D followed by six to nine digits). | [optional] |
|
|
12
|
+
| **condition_name** | **String** | The MeSH descriptor name of the condition. | [optional] |
|
|
13
|
+
| **disease_rank** | **Integer** | The condition's rank among the company's disease areas by trial count (1 is the busiest). Only the top 10 are kept. | [optional] |
|
|
14
|
+
| **collaborator_company_id** | **String** | Company level: the company that co-sponsors the trials. | [optional] |
|
|
15
|
+
| **collaborator_company_name** | **String** | Display name of the collaborator's company. | [optional] |
|
|
16
|
+
| **collaborator_group_id** | **String** | Group level: the collaborator's current ultimate parent; a root's group is itself. | [optional] |
|
|
17
|
+
| **collaborator_group_name** | **String** | Display name of the collaborator's group. | [optional] |
|
|
18
|
+
| **collaborator_rank** | **Integer** | 0 for the company itself, 1 to 6 for its collaborators ranked by shared trials across its top disease areas. | [optional] |
|
|
19
|
+
| **shared_trials** | **Integer** | Distinct trials the company shares with the collaborator in this disease area (for rank 0, the company's own trials in it). | [optional] |
|
|
20
|
+
|
|
21
|
+
## Example
|
|
22
|
+
|
|
23
|
+
```ruby
|
|
24
|
+
require 'pharmaobservatory'
|
|
25
|
+
|
|
26
|
+
instance = PharmaObservatory::CompanyCollaboratorsRow.new(
|
|
27
|
+
company_id: null,
|
|
28
|
+
company_name: null,
|
|
29
|
+
group_id: null,
|
|
30
|
+
group_name: null,
|
|
31
|
+
condition_id: null,
|
|
32
|
+
condition_name: null,
|
|
33
|
+
disease_rank: null,
|
|
34
|
+
collaborator_company_id: null,
|
|
35
|
+
collaborator_company_name: null,
|
|
36
|
+
collaborator_group_id: null,
|
|
37
|
+
collaborator_group_name: null,
|
|
38
|
+
collaborator_rank: null,
|
|
39
|
+
shared_trials: null
|
|
40
|
+
)
|
|
41
|
+
```
|
|
42
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyCompetitorActivityResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**AnimalWelfareAssurancesResponseScope**](AnimalWelfareAssurancesResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<CompanyCompetitorActivityRow>**](CompanyCompetitorActivityRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**AnimalWelfareAssurancesResponseFreshness**](AnimalWelfareAssurancesResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**AnimalWelfareAssurancesResponseBuild**](AnimalWelfareAssurancesResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::CompanyCompetitorActivityResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,42 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyCompetitorActivityRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **company_id** | **String** | Company level: the company the row is about; the entry key for the companies object type. | [optional] |
|
|
8
|
+
| **company_name** | **String** | Display name of the company. | [optional] |
|
|
9
|
+
| **group_id** | **String** | Group level: the company's current ultimate parent; a root's group is itself. | [optional] |
|
|
10
|
+
| **group_name** | **String** | Display name of the group. | [optional] |
|
|
11
|
+
| **condition_id** | **String** | The condition key, a MeSH (Medical Subject Headings) descriptor id (D followed by six to nine digits). | [optional] |
|
|
12
|
+
| **condition_name** | **String** | The MeSH descriptor name of the condition. | [optional] |
|
|
13
|
+
| **disease_rank** | **Integer** | The condition's rank among the company's disease areas by trial count (1 is the busiest). Only the top 10 are kept. | [optional] |
|
|
14
|
+
| **competitor_company_id** | **String** | Company level: the company active in the same disease area. | [optional] |
|
|
15
|
+
| **competitor_company_name** | **String** | Display name of the competitor's company. | [optional] |
|
|
16
|
+
| **competitor_group_id** | **String** | Group level: the competitor's current ultimate parent; a root's group is itself. | [optional] |
|
|
17
|
+
| **competitor_group_name** | **String** | Display name of the competitor's group. | [optional] |
|
|
18
|
+
| **competitor_rank** | **Integer** | 0 for the company itself, 1 to 6 for the companies ranked by trial count across the company's top disease areas. | [optional] |
|
|
19
|
+
| **trials** | **Integer** | Distinct trials the company in this row has in the disease area. | [optional] |
|
|
20
|
+
|
|
21
|
+
## Example
|
|
22
|
+
|
|
23
|
+
```ruby
|
|
24
|
+
require 'pharmaobservatory'
|
|
25
|
+
|
|
26
|
+
instance = PharmaObservatory::CompanyCompetitorActivityRow.new(
|
|
27
|
+
company_id: null,
|
|
28
|
+
company_name: null,
|
|
29
|
+
group_id: null,
|
|
30
|
+
group_name: null,
|
|
31
|
+
condition_id: null,
|
|
32
|
+
condition_name: null,
|
|
33
|
+
disease_rank: null,
|
|
34
|
+
competitor_company_id: null,
|
|
35
|
+
competitor_company_name: null,
|
|
36
|
+
competitor_group_id: null,
|
|
37
|
+
competitor_group_name: null,
|
|
38
|
+
competitor_rank: null,
|
|
39
|
+
trials: null
|
|
40
|
+
)
|
|
41
|
+
```
|
|
42
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyCompetitorsResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**AnimalWelfareAssurancesResponseScope**](AnimalWelfareAssurancesResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<CompanyCompetitorsRow>**](CompanyCompetitorsRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**AnimalWelfareAssurancesResponseFreshness**](AnimalWelfareAssurancesResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**AnimalWelfareAssurancesResponseBuild**](AnimalWelfareAssurancesResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::CompanyCompetitorsResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,66 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyCompetitorsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **company_id** | **String** | Company level: the company the row is about; the entry key for the companies object type. | [optional] |
|
|
8
|
+
| **company_name** | **String** | Display name of the company. | [optional] |
|
|
9
|
+
| **group_id** | **String** | Group level: the company's current ultimate parent; a root's group is itself. | [optional] |
|
|
10
|
+
| **group_name** | **String** | Display name of the group. | [optional] |
|
|
11
|
+
| **competitor_company_id** | **String** | Company level: the competing company. | [optional] |
|
|
12
|
+
| **competitor_company_name** | **String** | Display name of the competitor's company. | [optional] |
|
|
13
|
+
| **competitor_group_id** | **String** | Group level: the competitor's current ultimate parent; a root's group is itself. | [optional] |
|
|
14
|
+
| **competitor_group_name** | **String** | Display name of the competitor's group. | [optional] |
|
|
15
|
+
| **competitor_rank** | **Integer** | The competitor's rank for the company by competitor_score (1 is the highest). | [optional] |
|
|
16
|
+
| **competitor_score** | **Float** | 100 times the weighted mean of the four similarities below, rounded to four places. | [optional] |
|
|
17
|
+
| **target_sim** | **Float** | Jaccard similarity, 0 to 1, of the two companies' molecular target sets. | [optional] |
|
|
18
|
+
| **mechanism_sim** | **Float** | Jaccard similarity, 0 to 1, of their mechanism sets (a target and its action). | [optional] |
|
|
19
|
+
| **indication_sim** | **Float** | Jaccard similarity, 0 to 1, of their top-25 disease area sets. | [optional] |
|
|
20
|
+
| **phase_sim** | **Float** | The fraction, 0 to 1, of the shared targets that both companies have taken to phase 2 or later. | [optional] |
|
|
21
|
+
| **n_shared_targets** | **Integer** | Molecular targets both companies pursue. | [optional] |
|
|
22
|
+
| **n_shared_mechanisms** | **Integer** | Mechanisms (target and action) both companies pursue. | [optional] |
|
|
23
|
+
| **n_shared_indications** | **Integer** | Disease areas both companies are in, within each one's top 25. | [optional] |
|
|
24
|
+
| **n_phase_overlap_targets** | **Integer** | Shared targets that both companies have taken to phase 2 or later. | [optional] |
|
|
25
|
+
| **n_company_targets** | **Integer** | Targets the company pursues (the Jaccard denominator). | [optional] |
|
|
26
|
+
| **n_competitor_targets** | **Integer** | Targets the competitor pursues. | [optional] |
|
|
27
|
+
| **n_company_indications** | **Integer** | Disease areas in the company's top 25. | [optional] |
|
|
28
|
+
| **n_competitor_indications** | **Integer** | Disease areas in the competitor's top 25. | [optional] |
|
|
29
|
+
| **top_shared_targets** | **Array<String>** | Up to 5 shared target gene symbols, by combined phase then combined trials. An empty list when none. | [optional] |
|
|
30
|
+
| **top_shared_indications** | **Array<String>** | Up to 5 shared disease area names, by combined trial count. An empty list when none. | [optional] |
|
|
31
|
+
| **top_shared_mechanisms** | **Array<String>** | Up to 3 shared mechanisms written as a gene symbol and an action, by combined phase then combined trials. An empty list when none. | [optional] |
|
|
32
|
+
|
|
33
|
+
## Example
|
|
34
|
+
|
|
35
|
+
```ruby
|
|
36
|
+
require 'pharmaobservatory'
|
|
37
|
+
|
|
38
|
+
instance = PharmaObservatory::CompanyCompetitorsRow.new(
|
|
39
|
+
company_id: null,
|
|
40
|
+
company_name: null,
|
|
41
|
+
group_id: null,
|
|
42
|
+
group_name: null,
|
|
43
|
+
competitor_company_id: null,
|
|
44
|
+
competitor_company_name: null,
|
|
45
|
+
competitor_group_id: null,
|
|
46
|
+
competitor_group_name: null,
|
|
47
|
+
competitor_rank: null,
|
|
48
|
+
competitor_score: null,
|
|
49
|
+
target_sim: null,
|
|
50
|
+
mechanism_sim: null,
|
|
51
|
+
indication_sim: null,
|
|
52
|
+
phase_sim: null,
|
|
53
|
+
n_shared_targets: null,
|
|
54
|
+
n_shared_mechanisms: null,
|
|
55
|
+
n_shared_indications: null,
|
|
56
|
+
n_phase_overlap_targets: null,
|
|
57
|
+
n_company_targets: null,
|
|
58
|
+
n_competitor_targets: null,
|
|
59
|
+
n_company_indications: null,
|
|
60
|
+
n_competitor_indications: null,
|
|
61
|
+
top_shared_targets: null,
|
|
62
|
+
top_shared_indications: null,
|
|
63
|
+
top_shared_mechanisms: null
|
|
64
|
+
)
|
|
65
|
+
```
|
|
66
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyFinancialsResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**AnimalWelfareAssurancesResponseScope**](AnimalWelfareAssurancesResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<CompanyFinancialsRow>**](CompanyFinancialsRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**AnimalWelfareAssurancesResponseFreshness**](AnimalWelfareAssurancesResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**AnimalWelfareAssurancesResponseBuild**](AnimalWelfareAssurancesResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::CompanyFinancialsResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,108 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyFinancialsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **company_id** | **String** | Company level: the company the row is about; the entry key for the companies object type. | [optional] |
|
|
8
|
+
| **company_name** | **String** | Display name of the company. | [optional] |
|
|
9
|
+
| **group_id** | **String** | Group level: the company's current ultimate parent; a root's group is itself. | [optional] |
|
|
10
|
+
| **group_name** | **String** | Display name of the group. | [optional] |
|
|
11
|
+
| **reporting_org_id** | **String** | Legal-entity level: the organization record that filed (the SEC filer). | [optional] |
|
|
12
|
+
| **fiscal_year** | **Integer** | The fiscal year the figures belong to. | [optional] |
|
|
13
|
+
| **is_public** | **Boolean** | True when the record has an SEC registration number and is a listed filer (a Form D issuer that is not listed is false). | [optional] |
|
|
14
|
+
| **edgar_cik** | **String** | The SEC registration number (CIK, Central Index Key) of the filer. | [optional] |
|
|
15
|
+
| **ticker** | **String** | The stock ticker. | [optional] |
|
|
16
|
+
| **exchange** | **String** | The primary exchange listing. | [optional] |
|
|
17
|
+
| **public_float_usd** | **Float** | The latest reported public float, in USD, repeated on every year row of the filer (a proxy for market value, not a live market capitalization). | [optional] |
|
|
18
|
+
| **public_float_fy** | **Integer** | The fiscal year of public_float_usd. | [optional] |
|
|
19
|
+
| **latest_shares_outstanding** | **Float** | The latest reported cover-page share count of the filer, repeated on every year row (the denominator of an ownership percentage). | [optional] |
|
|
20
|
+
| **latest_shares_outstanding_fy** | **Integer** | The fiscal year of latest_shares_outstanding. | [optional] |
|
|
21
|
+
| **latest_financial_fy** | **Integer** | The latest fiscal year the filer reported any line item. | [optional] |
|
|
22
|
+
| **revenue** | **Float** | Total revenue for the fiscal year, in USD (a non-USD filer is converted at the calendar-year average rate; null when no rate exists). | [optional] |
|
|
23
|
+
| **net_income** | **Float** | Net income for the fiscal year, in USD. | [optional] |
|
|
24
|
+
| **rnd** | **Float** | Research and development expense for the fiscal year, in USD. | [optional] |
|
|
25
|
+
| **assets** | **Float** | Total assets at the fiscal year end, in USD (converted at the year-end rate). | [optional] |
|
|
26
|
+
| **equity** | **Float** | Stockholders' equity at the fiscal year end, in USD. | [optional] |
|
|
27
|
+
| **public_float** | **Float** | The public float on the annual report cover (the value of shares held by non-affiliates at the most recent second fiscal quarter end), in USD, anchored to the fiscal year it was filed with. | [optional] |
|
|
28
|
+
| **cash** | **Float** | Cash and cash equivalents at the fiscal year end, in USD. | [optional] |
|
|
29
|
+
| **short_term_investments** | **Float** | Short-term investments at the fiscal year end, in USD. | [optional] |
|
|
30
|
+
| **cash_and_investments** | **Float** | Cash plus short-term investments (a missing investments line counts as zero), in USD; null when cash is null. | [optional] |
|
|
31
|
+
| **operating_cash_flow** | **Float** | Net cash from operating activities for the fiscal year, in USD; negative means burning. | [optional] |
|
|
32
|
+
| **shares_outstanding** | **Float** | Shares outstanding on the annual report cover date, a count (never currency-converted); the cover date falls 0 to 3 months after the fiscal year end. | [optional] |
|
|
33
|
+
| **stock_based_compensation** | **Float** | Stock-based compensation expense, in USD. | [optional] |
|
|
34
|
+
| **operating_expenses** | **Float** | Operating expenses, in USD. | [optional] |
|
|
35
|
+
| **dividends_paid** | **Float** | Dividends paid, in USD, as filed with no sign test (filers differ on whether an outflow is positive or negative). | [optional] |
|
|
36
|
+
| **eps_basic** | **Float** | Basic earnings per share, in USD. | [optional] |
|
|
37
|
+
| **eps_diluted** | **Float** | Diluted earnings per share, in USD. | [optional] |
|
|
38
|
+
| **total_liabilities** | **Float** | Total liabilities at the fiscal year end, in USD. | [optional] |
|
|
39
|
+
| **long_term_debt_noncurrent** | **Float** | The non-current portion of long-term debt, in USD (null for a filer that reports only a total). | [optional] |
|
|
40
|
+
| **long_term_debt_total** | **Float** | Long-term debt, current plus non-current, in USD. | [optional] |
|
|
41
|
+
| **intangible_assets** | **Float** | Intangible assets, in USD. | [optional] |
|
|
42
|
+
| **property_plant_equipment** | **Float** | Property, plant and equipment, in USD. | [optional] |
|
|
43
|
+
| **goodwill** | **Float** | Goodwill, in USD. | [optional] |
|
|
44
|
+
| **inventory** | **Float** | Inventory, in USD. | [optional] |
|
|
45
|
+
| **accounts_payable** | **Float** | Accounts payable, in USD. | [optional] |
|
|
46
|
+
| **accounts_receivable** | **Float** | Accounts receivable, in USD. | [optional] |
|
|
47
|
+
| **weighted_average_shares_basic** | **Float** | Weighted average basic shares, a count. | [optional] |
|
|
48
|
+
| **weighted_average_shares_diluted** | **Float** | Weighted average diluted shares, a count. | [optional] |
|
|
49
|
+
| **burn_basis_usd** | **Float** | The average operating cash flow over this fiscal year and the two before it (the years reported), in USD; negative means burning. | [optional] |
|
|
50
|
+
| **burn_basis_years** | **Integer** | How many reported years burn_basis_usd averages over, 1 to 3. | [optional] |
|
|
51
|
+
| **runway_months** | **Float** | Derived, not reported: cash_and_investments divided by the monthly burn (burn_basis_usd over 12), in months, rounded to 0.1. Null when the filer generated cash or has no cash figure. | [optional] |
|
|
52
|
+
| **sec_total_revenue_usd_millions** | **Float** | The filing-level total revenue extracted from the 10-K or 20-F, in USD millions (the line the revenue-by-drug chart draws over the per-product stack); null where no total was extracted. | [optional] |
|
|
53
|
+
|
|
54
|
+
## Example
|
|
55
|
+
|
|
56
|
+
```ruby
|
|
57
|
+
require 'pharmaobservatory'
|
|
58
|
+
|
|
59
|
+
instance = PharmaObservatory::CompanyFinancialsRow.new(
|
|
60
|
+
company_id: null,
|
|
61
|
+
company_name: null,
|
|
62
|
+
group_id: null,
|
|
63
|
+
group_name: null,
|
|
64
|
+
reporting_org_id: null,
|
|
65
|
+
fiscal_year: null,
|
|
66
|
+
is_public: null,
|
|
67
|
+
edgar_cik: null,
|
|
68
|
+
ticker: null,
|
|
69
|
+
exchange: null,
|
|
70
|
+
public_float_usd: null,
|
|
71
|
+
public_float_fy: null,
|
|
72
|
+
latest_shares_outstanding: null,
|
|
73
|
+
latest_shares_outstanding_fy: null,
|
|
74
|
+
latest_financial_fy: null,
|
|
75
|
+
revenue: null,
|
|
76
|
+
net_income: null,
|
|
77
|
+
rnd: null,
|
|
78
|
+
assets: null,
|
|
79
|
+
equity: null,
|
|
80
|
+
public_float: null,
|
|
81
|
+
cash: null,
|
|
82
|
+
short_term_investments: null,
|
|
83
|
+
cash_and_investments: null,
|
|
84
|
+
operating_cash_flow: null,
|
|
85
|
+
shares_outstanding: null,
|
|
86
|
+
stock_based_compensation: null,
|
|
87
|
+
operating_expenses: null,
|
|
88
|
+
dividends_paid: null,
|
|
89
|
+
eps_basic: null,
|
|
90
|
+
eps_diluted: null,
|
|
91
|
+
total_liabilities: null,
|
|
92
|
+
long_term_debt_noncurrent: null,
|
|
93
|
+
long_term_debt_total: null,
|
|
94
|
+
intangible_assets: null,
|
|
95
|
+
property_plant_equipment: null,
|
|
96
|
+
goodwill: null,
|
|
97
|
+
inventory: null,
|
|
98
|
+
accounts_payable: null,
|
|
99
|
+
accounts_receivable: null,
|
|
100
|
+
weighted_average_shares_basic: null,
|
|
101
|
+
weighted_average_shares_diluted: null,
|
|
102
|
+
burn_basis_usd: null,
|
|
103
|
+
burn_basis_years: null,
|
|
104
|
+
runway_months: null,
|
|
105
|
+
sec_total_revenue_usd_millions: null
|
|
106
|
+
)
|
|
107
|
+
```
|
|
108
|
+
|